-+ 0.00%
-+ 0.00%
-+ 0.00%

VentriPoint targets shift to subscription-based access for VMS+ cardiac imaging platform

PUBT·08/12/2026 15:19:01
Listen to the news
VentriPoint targets shift to subscription-based access for VMS+ cardiac imaging platform
  • VentriPoint Diagnostics outlined a commercial push to broaden access to VMS+ 4.0 via subscriptions, hospital demos, and engagement programs.
  • Strategy targets an 80/20 mix favoring subscription access over capital purchases to reduce procurement friction and speed adoption.
  • Device-as-a-Service subscriptions are planned to bundle installation, training, updates, and support to simplify rollout across qualified hospitals.
  • Near-term priorities include scaling evaluations, expanding distributor partnerships, and growing deployments in approved markets across North America and Europe.
  • Regulatory plan includes pursuing China clearance for VMS+ 4.0 via partner Lishman Global under the NMPA “green channel” pathway.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VentriPoint Diagnostics Ltd. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608120905PRIMZONEFULLFEED9808237) on August 12, 2026, and is solely responsible for the information contained therein.